샘플 요청 목록

 카트 문의
시장보고서
상품코드
1563845

세계의 의약품-의료기기 조합 제품 시장

Drug Device Combination Products
발행일: | 리서치사: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 페이지 정보: 영문 196 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

의약품-의료기기 조합 제품 시장은 2030년까지 1,587억 달러에 도달할 전망입니다.

2023년에 1,148억 달러로 추정된 의약품-의료기기 조합 제품 시장은 2030년에는 1,587억 달러에 이르고, 예측 기간 동안 복합 연간 성장률(CAGR)은 4.7%로 성장할 것으로 예측됩니다. 이 보고서에서 분석한 부문 중 하나인 경피 패치는 복합 연간 성장률(CAGR) 4.5%로 성장을 지속하고, 분석 기간 종료 시 534억 달러에 도달할 것으로 예측됩니다. 흡입기 부문의 성장률은 분석 기간 동안 복합 연간 성장률(CAGR) 5.8%로 추정됩니다.

미국 시장은 306억 달러로 추정, 중국은 복합 연간 성장률(CAGR) 8.3%로 성장할 것으로 예측됩니다.

미국의 의약품-의료기기 조합 제품 시장은 2023년에 306억 달러로 추정됐습니다. 세계의 2위 경제대국인 중국은 2030년까지 362억 달러 규모에 이를 것으로 예측되며, 예측 기간 동안 복합 연간 성장률(CAGR)은 8.3%입니다. 기타 주목할 만한 지역별 시장으로는 일본과 캐나다가 있으며, 분석 기간 중 복합 연간 성장률(CAGR)은 각각 1.8%와 4.9%로 예측되고 있습니다. 유럽에서는 독일이 복합 연간 성장률(CAGR) 2.1%로 성장할 것으로 예측됩니다.

세계의 의약품-의료기기 조합 제품 시장- 주요 동향과 촉진요인 정리

의약품-의료기기 조합 제품이란 무엇인가, 왜 중요한가?

의약품-의료기기 조합 제품은 다양한 병리에 대한 치료의 효능, 안전성, 편리성을 향상시키기 위해 약제, 장치, 때로는 생물제제를 조합한 혁신적인 치료 솔루션입니다. 이러한 제품은 시너지 효과를 통한 치료 성과 향상, 약물 전달의 표적화, 방출 제어, 부작용 감소 등을 제공하기 때문에 의료 산업에서 점점 더 중요해지고 있습니다. 일반적인 예로는 약물 용출 스텐트, 프리필드 주사기, 흡입기, 경피 패치, 약물 코팅이 적용된 임베디드 장치 등이 있습니다. 약물과 장치의 통합은 정확성, 관리, 환자의 어드레싱이 중요한 만성 질환 관리, 종양학, 심혈관 치료에 특히 가치가 있습니다. 개별화된 효과적인 치료법 수요가 높아짐에 따라, 의약품-의료기기 조합 제품은 현대 헬스케어에 필수적인 요소가 되고 있습니다.

기술의 진보는 의약품-의료기기 조합 제품 시장을 어떻게 견인하고 있는가?

기술의 진보는 의약품-의료기기 조합 제품 시장의 성장과 개척을 크게 뒷받침하고 있습니다. 마이크로니들 패치, 스마트 흡입기, 생체 흡수성 스텐트와 같은 약물 전달 시스템의 혁신은 환자의 컴플라이언스와 치료 효과를 향상시킵니다. 센서 및 무선 연결을 포함한 디지털 건강 기술의 도입은 환자의 어드레싱 및 약물 전달의 실시간 모니터링을 가능하게 하고 치료 계획을 최적화하기 위한 귀중한 데이터를 의료 제공업체에게 제공합니다. 또한 생체적합성 고분자 및 하이드로겔과 같은 신소재의 개발은 임베디드 디바이스의 안전성과 효능을 향상시키고 부작용의 위험을 감소시킵니다. 또한 콤비네이션 제품의 제조에 3D 프린팅 기술을 사용하여 보다 정교한 맞춤화와 정확성을 제공하여 개별 환자의 특정 요구에 부응할 수 있습니다. 이러한 기술의 진보는 미충족 요구에 대응하는 혁신적인 솔루션을 제공함으로써 시장 상황을 변화시키고 있습니다.

규제경로와 시장 역학은 의약품-의료기기 조합 제품에 어떤 영향을 주고 있는가?

의약품/의료기기 조합 제품의 규제 상황은 복잡하며, 이들 제품은 의약품과 의료기기의 규제 기준을 모두 충족해야 합니다. FDA와 EMA와 같은 규제기관은 병용제품의 승인과정을 간소화하고, 안전성과 유효성을 확보하면서 시장 투입까지의 시간을 단축하기 위한 구체적인 가이드라인을 책정하고 있습니다. 이러한 규제 프레임워크은 제제의 개발과 상업화를 위한 명확한 경로를 제공함으로써 기술 혁신을 촉진하고 있습니다. 만성질환의 유병률 상승, 고령화, 저침습치료에 대한 수요 등 시장 역학은 의약품-의료기기 조합 제품의 채용을 더욱 뒷받침하고 있습니다. 또한 환자 중심의 치료에 대한 관심과 비용 효과적인 건강 관리 솔루션의 필요성은 치료 결과를 개선하고 입원 기간을 단축함으로써 이러한 제품의 사용을 촉진합니다.

의약품-의료기기 조합 제품 시장의 성장을 가속하는 요인은?

의약품-의료기기 조합 제품 시장의 성장은 기술의 진보, 유리한 규제 환경, 만성 질환의 유병률의 상승 등 여러 요인에 의해 견인되고 있습니다. 주요 촉진요인은 환자의 컴플라이언스와 치료 성적이 향상되는 낮은 침습 치료에 대한 수요 증가입니다. 또한 디지털 헬스 기술과 스마트 약물전달 시스템의 채용이 확대되고 있는 것도, 병용 제품의 유효성과 편의성을 높여, 헬스 케어 프로바이더와 환자 모두에게 보다 매력적인 것이 되고 있습니다. 또한 신흥국 시장의 의료 인프라 확대와 맞춤형 의료에 대한 관심 증가가 이러한 제품의 개발과 채용을 뒷받침하고 있습니다. 제약회사, 의료기기 제조업체, 연구기관의 전략적 제휴는 기술 혁신과 시장 성장을 더욱 강화하고 있습니다. 이러한 요인은 재료 과학 및 약제 처방 기술의 끊임없는 진보와 함께 의약품과 의료기기 조합 제품 시장을 전진시키고 있습니다.

조사 대상 기업 예(전 46건)

  • Abbott Laboratories
  • Alcon, a Novartis Company
  • Allergan PLC
  • Arrow International, Inc.
  • Bausch & Lomb, Inc.
  • Boston Scientific Corporation
  • CR Bard, Inc.
  • CareFusion Corporation
  • Ethicon US LLC
  • Medline Industries, Inc.
  • Medtronic PLC
  • Mylan NV
  • Stryker Corporation
  • Terumo Corporation
  • WL Gore & Associates, Inc.

목차

제1장 조사 방법

제2장 주요 요약

  • 시장 개요
  • 주요 기업
  • 시장 동향과 촉진요인
  • 시장 전망

제3장 시장 분석

  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 스페인
  • 러시아
  • 기타 유럽
  • 아시아태평양
  • 호주
  • 인도
  • 한국
  • 기타 아시아태평양
  • 라틴아메리카
  • 아르헨티나
  • 브라질
  • 멕시코
  • 기타 라틴아메리카
  • 중동
  • 이란
  • 이스라엘
  • 사우디아라비아
  • 아랍에미리트(UAE)
  • 기타 중동
  • 아프리카

제4장 경쟁

BJH 24.10.08

Global Drug Device Combination Products Market to Reach US$158.7 Billion by 2030

The global market for Drug Device Combination Products estimated at US$114.8 Billion in the year 2023, is expected to reach US$158.7 Billion by 2030, growing at a CAGR of 4.7% over the analysis period 2023-2030. Transdermal Patches, one of the segments analyzed in the report, is expected to record a 4.5% CAGR and reach US$53.4 Billion by the end of the analysis period. Growth in the Inhalers segment is estimated at 5.8% CAGR over the analysis period.

The U.S. Market is Estimated at US$30.6 Billion While China is Forecast to Grow at 8.3% CAGR

The Drug Device Combination Products market in the U.S. is estimated at US$30.6 Billion in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$36.2 Billion by the year 2030 trailing a CAGR of 8.3% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.8% and 4.9% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.1% CAGR.

Global Drug Device Combination Products Market - Key Trends & Drivers Summarized

What Are Drug Device Combination Products And Why Are They Important?

Drug device combination products are innovative therapeutic solutions that combine drugs, devices, and sometimes biologics to improve the efficacy, safety, and convenience of treatment for various medical conditions. These products are increasingly gaining importance in the healthcare industry as they offer enhanced treatment outcomes through synergistic effects, providing targeted drug delivery, controlled release, and reduced side effects. Common examples include drug-eluting stents, prefilled syringes, inhalers, transdermal patches, and implantable devices with drug coatings. The integration of drugs and devices is particularly valuable in chronic disease management, oncology, and cardiovascular treatments, where precision, control, and patient adherence are critical. As the demand for personalized and effective treatment options grows, drug device combination products are becoming an essential component of modern healthcare.

How Are Technological Advancements Driving The Drug Device Combination Products Market?

Technological advancements are significantly driving the growth and development of the drug device combination products market. Innovations in drug delivery systems, such as microneedle patches, smart inhalers, and bioresorbable stents, are enhancing patient compliance and therapeutic effectiveness. The incorporation of digital health technologies, including sensors and wireless connectivity, is enabling real-time monitoring of patient adherence and drug delivery, providing valuable data to healthcare providers for optimizing treatment plans. Additionally, the development of novel materials, such as biocompatible polymers and hydrogels, is improving the safety and efficacy of implantable devices, reducing the risk of adverse reactions. The use of 3D printing technology in manufacturing combination products is also allowing for greater customization and precision, catering to the specific needs of individual patients. These technological advancements are transforming the market landscape by offering innovative solutions that address unmet clinical needs.

How Are Regulatory Pathways And Market Dynamics Impacting Drug Device Combination Products?

The regulatory landscape for drug device combination products is complex, as these products must meet the standards of both drug and device regulations. Regulatory bodies such as the FDA and EMA are increasingly developing specific guidelines to streamline the approval process for combination products, ensuring safety and efficacy while reducing time to market. These regulatory frameworks are encouraging innovation by providing clearer pathways for the development and commercialization of combination products. Market dynamics, such as the rising prevalence of chronic diseases, the aging population, and the demand for minimally invasive treatments, are further driving the adoption of drug device combination products. The increasing focus on patient-centric care and the need for cost-effective healthcare solutions are also promoting the use of these products, as they offer improved treatment outcomes and reduced hospital stays.

What Factors Are Driving The Growth Of The Drug Device Combination Products Market?

The growth in the drug device combination products market is driven by several factors, including technological advancements, favorable regulatory environments, and the rising prevalence of chronic diseases. A key driver is the increasing demand for minimally invasive treatments that offer better patient compliance and outcomes. The growing adoption of digital health technologies and smart drug delivery systems is also enhancing the effectiveness and convenience of combination products, making them more attractive to both healthcare providers and patients. Additionally, the expansion of healthcare infrastructure in emerging markets and the increasing focus on personalized medicine are supporting the development and adoption of these products. Strategic collaborations between pharmaceutical companies, medical device manufacturers, and research institutions are further propelling innovation and market growth. These factors, coupled with the continuous advancement of materials science and drug formulation technologies, are driving the global market for drug device combination products forward.

Select Competitors (Total 46 Featured) -

  • Abbott Laboratories
  • Alcon, a Novartis Company
  • Allergan PLC
  • Arrow International, Inc.
  • Bausch & Lomb, Inc.
  • Boston Scientific Corporation
  • C.R. Bard, Inc.
  • CareFusion Corporation
  • Ethicon US LLC
  • Medline Industries, Inc.
  • Medtronic PLC
  • Mylan NV
  • Stryker Corporation
  • Terumo Corporation
  • W. L. Gore & Associates, Inc.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Impact of Covid-19 and a Looming Global Recession
    • Drug Device Combination Products - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Demand for Minimally Invasive Treatment Solutions
    • Increasing Adoption of Drug-Eluting Stents and Implantable Devices
    • Technological Advancements in Drug Delivery Mechanisms for Enhanced Efficacy
    • Growing Focus on Patient-Centric and Personalized Healthcare Solutions
    • Expansion of Applications for Combination Products in Chronic Disease Management
    • Impact of Regulatory Approvals and Fast-Track Designations on Market Growth
    • Increasing Collaborations Between Pharmaceutical and Medical Device Companies
    • Development of Smart Drug Device Combinations with Digital Health Integration
    • Rising Demand for Biodegradable and Implantable Drug Delivery Systems
    • Impact of Aging Population and Growing Burden of Chronic Diseases
    • Growing Investments in R&D for Novel Combination Products
    • Emerging Opportunities in Emerging Markets for Drug Device Combinations
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Drug Device Combination Products Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Drug Device Combination Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Drug Device Combination Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 4: World 16-Year Perspective for Drug Device Combination Products by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Transdermal Patches by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Transdermal Patches by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 7: World 16-Year Perspective for Transdermal Patches by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Inhalers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Inhalers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 10: World 16-Year Perspective for Inhalers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Drug Eluting Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Drug Eluting Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 13: World 16-Year Perspective for Drug Eluting Stents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Prefilled Syringes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Prefilled Syringes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 16: World 16-Year Perspective for Prefilled Syringes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Photodynamic Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Photodynamic Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 19: World 16-Year Perspective for Photodynamic Therapy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Nebulizers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Nebulizers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 22: World 16-Year Perspective for Nebulizers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Antimicrobial Wound Dressings by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Antimicrobial Wound Dressings by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 25: World 16-Year Perspective for Antimicrobial Wound Dressings by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Other Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Other Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 28: World 16-Year Perspective for Other Products by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Hospitals & Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Hospitals & Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 31: World 16-Year Perspective for Hospitals & Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for Home Care Setting by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 33: World Historic Review for Home Care Setting by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 34: World 16-Year Perspective for Home Care Setting by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 35: World Recent Past, Current & Future Analysis for Ambulatory Surgery Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 36: World Historic Review for Ambulatory Surgery Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 37: World 16-Year Perspective for Ambulatory Surgery Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 38: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 39: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 40: World 16-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Drug Device Combination Products Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 41: USA Recent Past, Current & Future Analysis for Drug Device Combination Products by Product - Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 42: USA Historic Review for Drug Device Combination Products by Product - Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 43: USA 16-Year Perspective for Drug Device Combination Products by Product - Percentage Breakdown of Value Sales for Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products for the Years 2014, 2024 & 2030
    • TABLE 44: USA Recent Past, Current & Future Analysis for Drug Device Combination Products by End-Use - Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 45: USA Historic Review for Drug Device Combination Products by End-Use - Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 46: USA 16-Year Perspective for Drug Device Combination Products by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 47: Canada Recent Past, Current & Future Analysis for Drug Device Combination Products by Product - Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 48: Canada Historic Review for Drug Device Combination Products by Product - Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 49: Canada 16-Year Perspective for Drug Device Combination Products by Product - Percentage Breakdown of Value Sales for Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products for the Years 2014, 2024 & 2030
    • TABLE 50: Canada Recent Past, Current & Future Analysis for Drug Device Combination Products by End-Use - Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 51: Canada Historic Review for Drug Device Combination Products by End-Use - Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 52: Canada 16-Year Perspective for Drug Device Combination Products by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • JAPAN
    • Drug Device Combination Products Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 53: Japan Recent Past, Current & Future Analysis for Drug Device Combination Products by Product - Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 54: Japan Historic Review for Drug Device Combination Products by Product - Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 55: Japan 16-Year Perspective for Drug Device Combination Products by Product - Percentage Breakdown of Value Sales for Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products for the Years 2014, 2024 & 2030
    • TABLE 56: Japan Recent Past, Current & Future Analysis for Drug Device Combination Products by End-Use - Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 57: Japan Historic Review for Drug Device Combination Products by End-Use - Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 58: Japan 16-Year Perspective for Drug Device Combination Products by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • CHINA
    • Drug Device Combination Products Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 59: China Recent Past, Current & Future Analysis for Drug Device Combination Products by Product - Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 60: China Historic Review for Drug Device Combination Products by Product - Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 61: China 16-Year Perspective for Drug Device Combination Products by Product - Percentage Breakdown of Value Sales for Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products for the Years 2014, 2024 & 2030
    • TABLE 62: China Recent Past, Current & Future Analysis for Drug Device Combination Products by End-Use - Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 63: China Historic Review for Drug Device Combination Products by End-Use - Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 64: China 16-Year Perspective for Drug Device Combination Products by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • EUROPE
    • Drug Device Combination Products Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 65: Europe Recent Past, Current & Future Analysis for Drug Device Combination Products by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 66: Europe Historic Review for Drug Device Combination Products by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 67: Europe 16-Year Perspective for Drug Device Combination Products by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 68: Europe Recent Past, Current & Future Analysis for Drug Device Combination Products by Product - Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 69: Europe Historic Review for Drug Device Combination Products by Product - Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 70: Europe 16-Year Perspective for Drug Device Combination Products by Product - Percentage Breakdown of Value Sales for Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products for the Years 2014, 2024 & 2030
    • TABLE 71: Europe Recent Past, Current & Future Analysis for Drug Device Combination Products by End-Use - Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 72: Europe Historic Review for Drug Device Combination Products by End-Use - Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 73: Europe 16-Year Perspective for Drug Device Combination Products by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • FRANCE
    • Drug Device Combination Products Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 74: France Recent Past, Current & Future Analysis for Drug Device Combination Products by Product - Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 75: France Historic Review for Drug Device Combination Products by Product - Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 76: France 16-Year Perspective for Drug Device Combination Products by Product - Percentage Breakdown of Value Sales for Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products for the Years 2014, 2024 & 2030
    • TABLE 77: France Recent Past, Current & Future Analysis for Drug Device Combination Products by End-Use - Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 78: France Historic Review for Drug Device Combination Products by End-Use - Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 79: France 16-Year Perspective for Drug Device Combination Products by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • GERMANY
    • Drug Device Combination Products Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 80: Germany Recent Past, Current & Future Analysis for Drug Device Combination Products by Product - Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 81: Germany Historic Review for Drug Device Combination Products by Product - Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 82: Germany 16-Year Perspective for Drug Device Combination Products by Product - Percentage Breakdown of Value Sales for Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products for the Years 2014, 2024 & 2030
    • TABLE 83: Germany Recent Past, Current & Future Analysis for Drug Device Combination Products by End-Use - Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 84: Germany Historic Review for Drug Device Combination Products by End-Use - Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 85: Germany 16-Year Perspective for Drug Device Combination Products by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 86: Italy Recent Past, Current & Future Analysis for Drug Device Combination Products by Product - Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 87: Italy Historic Review for Drug Device Combination Products by Product - Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 88: Italy 16-Year Perspective for Drug Device Combination Products by Product - Percentage Breakdown of Value Sales for Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products for the Years 2014, 2024 & 2030
    • TABLE 89: Italy Recent Past, Current & Future Analysis for Drug Device Combination Products by End-Use - Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 90: Italy Historic Review for Drug Device Combination Products by End-Use - Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 91: Italy 16-Year Perspective for Drug Device Combination Products by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Drug Device Combination Products Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 92: UK Recent Past, Current & Future Analysis for Drug Device Combination Products by Product - Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 93: UK Historic Review for Drug Device Combination Products by Product - Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 94: UK 16-Year Perspective for Drug Device Combination Products by Product - Percentage Breakdown of Value Sales for Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products for the Years 2014, 2024 & 2030
    • TABLE 95: UK Recent Past, Current & Future Analysis for Drug Device Combination Products by End-Use - Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 96: UK Historic Review for Drug Device Combination Products by End-Use - Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 97: UK 16-Year Perspective for Drug Device Combination Products by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • SPAIN
    • TABLE 98: Spain Recent Past, Current & Future Analysis for Drug Device Combination Products by Product - Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 99: Spain Historic Review for Drug Device Combination Products by Product - Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 100: Spain 16-Year Perspective for Drug Device Combination Products by Product - Percentage Breakdown of Value Sales for Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products for the Years 2014, 2024 & 2030
    • TABLE 101: Spain Recent Past, Current & Future Analysis for Drug Device Combination Products by End-Use - Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 102: Spain Historic Review for Drug Device Combination Products by End-Use - Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 103: Spain 16-Year Perspective for Drug Device Combination Products by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • RUSSIA
    • TABLE 104: Russia Recent Past, Current & Future Analysis for Drug Device Combination Products by Product - Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 105: Russia Historic Review for Drug Device Combination Products by Product - Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 106: Russia 16-Year Perspective for Drug Device Combination Products by Product - Percentage Breakdown of Value Sales for Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products for the Years 2014, 2024 & 2030
    • TABLE 107: Russia Recent Past, Current & Future Analysis for Drug Device Combination Products by End-Use - Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 108: Russia Historic Review for Drug Device Combination Products by End-Use - Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 109: Russia 16-Year Perspective for Drug Device Combination Products by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 110: Rest of Europe Recent Past, Current & Future Analysis for Drug Device Combination Products by Product - Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 111: Rest of Europe Historic Review for Drug Device Combination Products by Product - Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 112: Rest of Europe 16-Year Perspective for Drug Device Combination Products by Product - Percentage Breakdown of Value Sales for Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products for the Years 2014, 2024 & 2030
    • TABLE 113: Rest of Europe Recent Past, Current & Future Analysis for Drug Device Combination Products by End-Use - Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 114: Rest of Europe Historic Review for Drug Device Combination Products by End-Use - Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 115: Rest of Europe 16-Year Perspective for Drug Device Combination Products by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Drug Device Combination Products Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 116: Asia-Pacific Recent Past, Current & Future Analysis for Drug Device Combination Products by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 117: Asia-Pacific Historic Review for Drug Device Combination Products by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 118: Asia-Pacific 16-Year Perspective for Drug Device Combination Products by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
    • TABLE 119: Asia-Pacific Recent Past, Current & Future Analysis for Drug Device Combination Products by Product - Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 120: Asia-Pacific Historic Review for Drug Device Combination Products by Product - Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 121: Asia-Pacific 16-Year Perspective for Drug Device Combination Products by Product - Percentage Breakdown of Value Sales for Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products for the Years 2014, 2024 & 2030
    • TABLE 122: Asia-Pacific Recent Past, Current & Future Analysis for Drug Device Combination Products by End-Use - Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 123: Asia-Pacific Historic Review for Drug Device Combination Products by End-Use - Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 124: Asia-Pacific 16-Year Perspective for Drug Device Combination Products by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • AUSTRALIA
    • Drug Device Combination Products Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
    • TABLE 125: Australia Recent Past, Current & Future Analysis for Drug Device Combination Products by Product - Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 126: Australia Historic Review for Drug Device Combination Products by Product - Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 127: Australia 16-Year Perspective for Drug Device Combination Products by Product - Percentage Breakdown of Value Sales for Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products for the Years 2014, 2024 & 2030
    • TABLE 128: Australia Recent Past, Current & Future Analysis for Drug Device Combination Products by End-Use - Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 129: Australia Historic Review for Drug Device Combination Products by End-Use - Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 130: Australia 16-Year Perspective for Drug Device Combination Products by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • INDIA
    • Drug Device Combination Products Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
    • TABLE 131: India Recent Past, Current & Future Analysis for Drug Device Combination Products by Product - Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 132: India Historic Review for Drug Device Combination Products by Product - Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 133: India 16-Year Perspective for Drug Device Combination Products by Product - Percentage Breakdown of Value Sales for Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products for the Years 2014, 2024 & 2030
    • TABLE 134: India Recent Past, Current & Future Analysis for Drug Device Combination Products by End-Use - Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 135: India Historic Review for Drug Device Combination Products by End-Use - Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 136: India 16-Year Perspective for Drug Device Combination Products by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • SOUTH KOREA
    • TABLE 137: South Korea Recent Past, Current & Future Analysis for Drug Device Combination Products by Product - Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 138: South Korea Historic Review for Drug Device Combination Products by Product - Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 139: South Korea 16-Year Perspective for Drug Device Combination Products by Product - Percentage Breakdown of Value Sales for Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products for the Years 2014, 2024 & 2030
    • TABLE 140: South Korea Recent Past, Current & Future Analysis for Drug Device Combination Products by End-Use - Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 141: South Korea Historic Review for Drug Device Combination Products by End-Use - Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 142: South Korea 16-Year Perspective for Drug Device Combination Products by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 143: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Drug Device Combination Products by Product - Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 144: Rest of Asia-Pacific Historic Review for Drug Device Combination Products by Product - Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 145: Rest of Asia-Pacific 16-Year Perspective for Drug Device Combination Products by Product - Percentage Breakdown of Value Sales for Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products for the Years 2014, 2024 & 2030
    • TABLE 146: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Drug Device Combination Products by End-Use - Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 147: Rest of Asia-Pacific Historic Review for Drug Device Combination Products by End-Use - Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 148: Rest of Asia-Pacific 16-Year Perspective for Drug Device Combination Products by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • LATIN AMERICA
    • Drug Device Combination Products Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
    • TABLE 149: Latin America Recent Past, Current & Future Analysis for Drug Device Combination Products by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 150: Latin America Historic Review for Drug Device Combination Products by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 151: Latin America 16-Year Perspective for Drug Device Combination Products by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2024 & 2030
    • TABLE 152: Latin America Recent Past, Current & Future Analysis for Drug Device Combination Products by Product - Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 153: Latin America Historic Review for Drug Device Combination Products by Product - Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 154: Latin America 16-Year Perspective for Drug Device Combination Products by Product - Percentage Breakdown of Value Sales for Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products for the Years 2014, 2024 & 2030
    • TABLE 155: Latin America Recent Past, Current & Future Analysis for Drug Device Combination Products by End-Use - Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 156: Latin America Historic Review for Drug Device Combination Products by End-Use - Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 157: Latin America 16-Year Perspective for Drug Device Combination Products by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • ARGENTINA
    • TABLE 158: Argentina Recent Past, Current & Future Analysis for Drug Device Combination Products by Product - Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 159: Argentina Historic Review for Drug Device Combination Products by Product - Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 160: Argentina 16-Year Perspective for Drug Device Combination Products by Product - Percentage Breakdown of Value Sales for Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products for the Years 2014, 2024 & 2030
    • TABLE 161: Argentina Recent Past, Current & Future Analysis for Drug Device Combination Products by End-Use - Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 162: Argentina Historic Review for Drug Device Combination Products by End-Use - Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 163: Argentina 16-Year Perspective for Drug Device Combination Products by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • BRAZIL
    • TABLE 164: Brazil Recent Past, Current & Future Analysis for Drug Device Combination Products by Product - Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 165: Brazil Historic Review for Drug Device Combination Products by Product - Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 166: Brazil 16-Year Perspective for Drug Device Combination Products by Product - Percentage Breakdown of Value Sales for Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products for the Years 2014, 2024 & 2030
    • TABLE 167: Brazil Recent Past, Current & Future Analysis for Drug Device Combination Products by End-Use - Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 168: Brazil Historic Review for Drug Device Combination Products by End-Use - Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 169: Brazil 16-Year Perspective for Drug Device Combination Products by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • MEXICO
    • TABLE 170: Mexico Recent Past, Current & Future Analysis for Drug Device Combination Products by Product - Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 171: Mexico Historic Review for Drug Device Combination Products by Product - Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 172: Mexico 16-Year Perspective for Drug Device Combination Products by Product - Percentage Breakdown of Value Sales for Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products for the Years 2014, 2024 & 2030
    • TABLE 173: Mexico Recent Past, Current & Future Analysis for Drug Device Combination Products by End-Use - Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 174: Mexico Historic Review for Drug Device Combination Products by End-Use - Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 175: Mexico 16-Year Perspective for Drug Device Combination Products by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • REST OF LATIN AMERICA
    • TABLE 176: Rest of Latin America Recent Past, Current & Future Analysis for Drug Device Combination Products by Product - Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 177: Rest of Latin America Historic Review for Drug Device Combination Products by Product - Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 178: Rest of Latin America 16-Year Perspective for Drug Device Combination Products by Product - Percentage Breakdown of Value Sales for Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products for the Years 2014, 2024 & 2030
    • TABLE 179: Rest of Latin America Recent Past, Current & Future Analysis for Drug Device Combination Products by End-Use - Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 180: Rest of Latin America Historic Review for Drug Device Combination Products by End-Use - Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 181: Rest of Latin America 16-Year Perspective for Drug Device Combination Products by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • MIDDLE EAST
    • Drug Device Combination Products Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
    • TABLE 182: Middle East Recent Past, Current & Future Analysis for Drug Device Combination Products by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 183: Middle East Historic Review for Drug Device Combination Products by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 184: Middle East 16-Year Perspective for Drug Device Combination Products by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2024 & 2030
    • TABLE 185: Middle East Recent Past, Current & Future Analysis for Drug Device Combination Products by Product - Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 186: Middle East Historic Review for Drug Device Combination Products by Product - Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 187: Middle East 16-Year Perspective for Drug Device Combination Products by Product - Percentage Breakdown of Value Sales for Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products for the Years 2014, 2024 & 2030
    • TABLE 188: Middle East Recent Past, Current & Future Analysis for Drug Device Combination Products by End-Use - Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 189: Middle East Historic Review for Drug Device Combination Products by End-Use - Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 190: Middle East 16-Year Perspective for Drug Device Combination Products by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • IRAN
    • TABLE 191: Iran Recent Past, Current & Future Analysis for Drug Device Combination Products by Product - Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 192: Iran Historic Review for Drug Device Combination Products by Product - Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 193: Iran 16-Year Perspective for Drug Device Combination Products by Product - Percentage Breakdown of Value Sales for Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products for the Years 2014, 2024 & 2030
    • TABLE 194: Iran Recent Past, Current & Future Analysis for Drug Device Combination Products by End-Use - Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 195: Iran Historic Review for Drug Device Combination Products by End-Use - Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 196: Iran 16-Year Perspective for Drug Device Combination Products by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • ISRAEL
    • TABLE 197: Israel Recent Past, Current & Future Analysis for Drug Device Combination Products by Product - Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 198: Israel Historic Review for Drug Device Combination Products by Product - Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 199: Israel 16-Year Perspective for Drug Device Combination Products by Product - Percentage Breakdown of Value Sales for Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products for the Years 2014, 2024 & 2030
    • TABLE 200: Israel Recent Past, Current & Future Analysis for Drug Device Combination Products by End-Use - Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 201: Israel Historic Review for Drug Device Combination Products by End-Use - Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 202: Israel 16-Year Perspective for Drug Device Combination Products by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • SAUDI ARABIA
    • TABLE 203: Saudi Arabia Recent Past, Current & Future Analysis for Drug Device Combination Products by Product - Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 204: Saudi Arabia Historic Review for Drug Device Combination Products by Product - Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 205: Saudi Arabia 16-Year Perspective for Drug Device Combination Products by Product - Percentage Breakdown of Value Sales for Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products for the Years 2014, 2024 & 2030
    • TABLE 206: Saudi Arabia Recent Past, Current & Future Analysis for Drug Device Combination Products by End-Use - Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 207: Saudi Arabia Historic Review for Drug Device Combination Products by End-Use - Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 208: Saudi Arabia 16-Year Perspective for Drug Device Combination Products by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 209: UAE Recent Past, Current & Future Analysis for Drug Device Combination Products by Product - Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 210: UAE Historic Review for Drug Device Combination Products by Product - Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 211: UAE 16-Year Perspective for Drug Device Combination Products by Product - Percentage Breakdown of Value Sales for Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products for the Years 2014, 2024 & 2030
    • TABLE 212: UAE Recent Past, Current & Future Analysis for Drug Device Combination Products by End-Use - Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 213: UAE Historic Review for Drug Device Combination Products by End-Use - Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 214: UAE 16-Year Perspective for Drug Device Combination Products by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • REST OF MIDDLE EAST
    • TABLE 215: Rest of Middle East Recent Past, Current & Future Analysis for Drug Device Combination Products by Product - Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 216: Rest of Middle East Historic Review for Drug Device Combination Products by Product - Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 217: Rest of Middle East 16-Year Perspective for Drug Device Combination Products by Product - Percentage Breakdown of Value Sales for Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products for the Years 2014, 2024 & 2030
    • TABLE 218: Rest of Middle East Recent Past, Current & Future Analysis for Drug Device Combination Products by End-Use - Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 219: Rest of Middle East Historic Review for Drug Device Combination Products by End-Use - Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 220: Rest of Middle East 16-Year Perspective for Drug Device Combination Products by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • AFRICA
    • Drug Device Combination Products Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
    • TABLE 221: Africa Recent Past, Current & Future Analysis for Drug Device Combination Products by Product - Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 222: Africa Historic Review for Drug Device Combination Products by Product - Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 223: Africa 16-Year Perspective for Drug Device Combination Products by Product - Percentage Breakdown of Value Sales for Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products for the Years 2014, 2024 & 2030
    • TABLE 224: Africa Recent Past, Current & Future Analysis for Drug Device Combination Products by End-Use - Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 225: Africa Historic Review for Drug Device Combination Products by End-Use - Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 226: Africa 16-Year Perspective for Drug Device Combination Products by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses for the Years 2014, 2024 & 2030

IV. COMPETITION

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제